We are international
Donate
TEXT SIZE   


Dr. McCarthy - Phase III Intergroup Study of Lenalidomide Versus Placebo Maintenance Therapy Following Single Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Myeloma: CALGB 100104
Philip L. McCarthy, MD
Buffalo, New York
USA
12.02.10


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles